Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N C Goodwin

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Human Factors|April 1, 1970
Computer-generated speech and man-computer interactionS L Smith, N C Goodwin
Human Factors|June 1, 1971
Blink coding for information displayS L Smith, N C Goodwin
Immunogenetics|January 1, 1992
The B6.CE-Lyb-2c:Mup-1a mouse strain contains the interferon-alpha genes from C57BL/6K A Gollahon, E A Boyse, N C Goodwin, et al.
The Pharmacogenomics Journal|June 14, 2017
Genetic background influences susceptibility to chemotherapy-induced hematotoxicityD M Gatti, S N Weber, N C Goodwin, et al.
Nature Genetics|August 2, 2001
DelBank: a mouse ES-cell resource for generating deletionsN C Goodwin, Y Ishida, S Hartford, et al.
Human Molecular Genetics|January 12, 2001
Mouse models for the Wolf-Hirschhorn deletion syndromeD Näf, L A Wilson, R A Bergstrom, et al.
Clinical Pharmacology and Therapeutics|June 29, 2012
LX4211, a dual SGLT1/SGLT2 inhibitor, improved glycemic control in patients with type 2 diabetes in a randomized, placebo-controlled trialB Zambrowicz, J Freiman, P M Brown, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Human Factors|April 1, 1970
Computer-generated speech and man-computer interactionS L Smith, N C Goodwin
Human Factors|June 1, 1971
Blink coding for information displayS L Smith, N C Goodwin
Immunogenetics|January 1, 1992
The B6.CE-Lyb-2c:Mup-1a mouse strain contains the interferon-alpha genes from C57BL/6K A Gollahon, E A Boyse, N C Goodwin, et al.
The Pharmacogenomics Journal|June 14, 2017
Genetic background influences susceptibility to chemotherapy-induced hematotoxicityD M Gatti, S N Weber, N C Goodwin, et al.
Nature Genetics|August 2, 2001
DelBank: a mouse ES-cell resource for generating deletionsN C Goodwin, Y Ishida, S Hartford, et al.
Human Molecular Genetics|January 12, 2001
Mouse models for the Wolf-Hirschhorn deletion syndromeD Näf, L A Wilson, R A Bergstrom, et al.
Clinical Pharmacology and Therapeutics|June 29, 2012
LX4211, a dual SGLT1/SGLT2 inhibitor, improved glycemic control in patients with type 2 diabetes in a randomized, placebo-controlled trialB Zambrowicz, J Freiman, P M Brown, et al.
Pageof 1